In a small study, patients who have successfully lost weight with weekly GLP-1 treatment maintain their weight loss and ...
Everyday Health on MSN
Can Taking a GLP-1 Drug Every Other Week Help You Keep the Weight Off?
A small new study suggests that people who’ve used GLP-1 drugs to reach a healthy weight can spread out their injections without regaining lost pounds.
Medpage Today on MSN
Novel Drug Led to Meaningful Weight Loss in Adults With Obesity
Subcutaneous injections of an investigational, selective long-acting amylin receptor agonist led to clinically meaningful ...
Early results of Eli Lilly’s next generation of weight loss drugs appear to show promise, possibly leading to even faster ...
Novo Nordisk’s oral semaglutide 25 mg achieved up to 16.6% weight loss in a landmark study, rivaling injectable Wegovy. The ...
IV therapy is gaining popularity as a new approach to wellness, delivering a personalized vitamin cocktail directly into the bloodstream. Nationwide, the industry has experienced significant growth, ...
A Trump administration deal to cut prices for popular weight-loss drugs like Wegovy and Zepbound will allow millions more ...
New non-human primate data projects a human half-life of up to 100 days, potentially enabling treatment with only ...
Hosted on MSN
Study suggests lean muscle mass loss can be minimized during weight loss therapy using newer incretin obesity drugs
New research to be presented at the European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) shows that patients using GLP-1 or combined GLP-1 / GIP receptor agonist therapy for weight loss ...
Ro, the leading direct-to-patient healthcare company, was selected to present eight new research abstracts at ObesityWeek ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback